Juvenile form of alexander disease caused by a previously undescribed mutation in the GFAP gene. a case report
https://doi.org/10.17650/2073-8803-2021-16-1-2-58-62
Abstract
Alexander disease is a form of leukoencephalopathy caused by mutations in the GFAP gene. There are three forms of the disease: infant, juvenile and adult. We present the clinical case of a patient born in 2004 (16 years old) with a debut of the disease at the age of 4 years with complex ticks. further neurological symptoms progressed and appeared atactic gait, intention tremor by performing coordination tests, muscle hypotension, decreased tendon reflexes, nasal voices, and behavior changes.
Magnetic resonance imaging revealed changes in the white matter of both frontal lobes. An analysis was made of 59 genes of the panel “Leukodystrophy/leukoencephalopathy” by the method of mass parallel sequencing on the Ion S5. A mutation of the GFAP gene (Nm_002055), 4 exon c.758C>A, p.ALA253Asp in a heterozygous state, not described in Human Gene mutation Database, was detected. The patient was confirmed to have a diagnosis of Alexander disease. According to tractography, a decrease in the number of fibers in the frontal lobes was found.
The patient is currently receiving symptomatic treatment.
About the Authors
A. I. Pavljuchkova
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Russian Federation
61/2 Shchepkina St., Moscow 129110
A. S. Kotov
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Russian Federation
Aleksey Sergeevich Kotov
61/2 Shchepkina St., Moscow 129110
References
1. Alexander W.S. Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain Oxford 1949;72:373–81.
2. Gass J.M., Cheema A., Jackson J. et al. Novel GFAP variant in adult-onset Alexander disease with progressive ataxia and palatal tremor. Neurologist 2017;22(6):247–8. DOI: 10.1097/NRL.0000000000000153.
3. Gómez-Pinedo U., Duran-Moreno M., Sirerol-Piquer S., Matias-Guiu J. Myelin changes in Alexander disease. Neurologia 2018;33(8):526–33. DOI: 10.1016/j.nrl.2017.01.019.
4. Lee S., Nam T., Kim K. et al. Aggregationprone GFAP mutation in Alexander disease validated using a zebrafish model. BMC Neurol 2017;17:175. DOI: 10.1186/s12883-017-0938-7.
5. Messing A. Alexander disease. Handbook Clin Neurol 2018;148:693–700. DOI: 10.1016/B978-0-444-64076-5.00044-2.
6. Messing A., LaPash Daniels C.M., Hagemann T.L. Strategies for treatment in Alexander disease. Neurotherapeutics 2010;7(4):507–15. DOI: 10.1016/j.nurt.2010.05.013.
7. Tavasoli A., Armangue T., Ho C.Y. et al. Alexander disease. J Clin Neurol 2017;32(2): 184–7. DOI: 10.1177/0883073816673263.
8. Yasuda R., Nakano M., Yoshida T. et al. Towards genomic database of Alexander disease to identify variations modifying disease phenotype. Sci Rep 2019;9:14763. DOI: 10.1038/s41598-019-51390-8.
Review
For citations:
Pavljuchkova A.I., Kotov A.S. Juvenile form of alexander disease caused by a previously undescribed mutation in the GFAP gene. a case report. Russian Journal of Child Neurology. 2021;16(1-2):58-62. (In Russ.) https://doi.org/10.17650/2073-8803-2021-16-1-2-58-62
Views:
1036
Email this article 